HOME › Top Market Reports › Refurbished Medical Equipments & Devices Market - [C-Arms, Cath Labs, Ultrasound, MRI, PET/SPECT, Radiation Oncology Systems, Minimally Invasive Devices, Spectrophotometers, Electrophoresis, Chromatography Systems] - Global Trends & Forecasts to 2017

Refurbished Medical Equipments & Devices Market - [C-Arms, Cath Labs, Ultrasound, MRI, PET/SPECT, Radiation Oncology Systems, Minimally Invasive Devices, Spectrophotometers, Electrophoresis, Chromatography Systems] - Global Trends & Forecasts to 2017

By: marketsandmarkets.com
Publishing Date: August 2012
Report Code: MD 1233

Refurbishment restores used equipment or systems through repairing, reworking, updating and replacing of worn parts with original parts to ensure a condition of safety and effectiveness comparable to when new. All process should be consistent with product specifications and service procedures defined by the original manufacturer for that equipment or system. These processes do not alter equipment’s or system’s performance, safety specifications and/or changes intended to use as in its original registration. This device market encompasses for imaging-monitoring-diagnostic devices, radiation oncology systems, minimally invasive surgical devices, biotechnology instruments and others.

The global refurbished medical equipments/device market is poised to reach $8.45 billion by 2017, at a CAGR of 7.8%. Biotechnology instruments and imaging-monitoring-diagnostic devices contribute to the maximum share (78%) to the global refurbished devices market, followed by minimally invasive surgical devices (16%) and radiation oncology systems (2%) in 2011.

The major driving factor for refurbished medical equipments/device market involves the affordable price range of refurbished devices that aid small and medium healthcare institutions to provide advanced treatment at lower rates. Developing countries in Latin America, Asia, and Middle East etc. are driving this market as they are becoming wealthier to welcome new medical equipments for serving advanced treatments, but not that much to afford purchasing brand new highly expensive medical equipments.

The imaging-monitoring-diagnostic devices segment in refurbished medical equipments/device market represents the highest growing segment. Refurbished imaging-monitoring-diagnostic devices market contributes to 17% of the global market.

North America, specifically the U.S., is contributing the maximum share to the refurbished medical device market. The U.S. market is primarily driven by huge amount of private practitioners. Developing countries such as Latin America, specifically Chile, Ecuador, Caribbean, Bolivia, Mexico, and Peru, are contributing largely to this growing market. The next market opportunities lie in the Asian market. India is the biggest market in the Asian regime due to its high population base and low affordability to purchase highly expensive brand new medical devices. The Asian market is deemed to be the most lucrative market place for these refurbished products in the near future.

This market is operated by mainly two kinds of players; original equipment manufacturers (OEMs) and third party manufacturers. Major OEMs include GE Healthcare (U.K.), Siemens Healthcare (Germany), Philips Healthcare (Netherlands), Stryker Corporation (U.S.), Johnson & Johnson (U.S.) and Toshiba medical system (Japan). A few noteworthy third party vendors include Soma Technology (U.S.), Agito Medical (Denmark), DMS Topline Medical (U.S.), and First Source, Inc. (U.S.).

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
      1.5.1 MARKET SIZE
      1.5.2 MARKET SHARE
      1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
      1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
      1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 REFURBISHED MEDICAL EQUIPMENTS MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
      3.3.1 DRIVERS
            3.3.1.1 Affordable channel to sustain in the high cost containment pressure
            3.3.1.2 Green-minded refurbishing programme, promoted by key market players
            3.3.1.3 Better technological advancement ensuring longer product life
            3.3.1.4 Increasing healthcare allocation in the developing countries
            3.3.1.5 Increasing interest of original manufacturers in this market
      3.3.2 RESTRAINTS
            3.3.2.1 Stringent regulation in the important global markets
            3.3.2.2 Misconception on the quality issue of refurbished products hindering the acceptance
            3.3.2.3 Public sector healthcare institute avoiding refurbished medical devices
      3.3.3 THREATS & OPPORTUNITIES
3.4 TRENDS
3.5 MARKET SHARE ANALYSIS OF MAJOR PLAYERS

4 GLOBAL REFURBISHED MEDICAL DEVICES MARKET
4.1 INTRODUCTION
4.2 IMAGING-DIAGNOSTIC-MONITORING SYSTEM
      4.2.1 X-RAY
      4.2.2 C-ARM
      4.2.3 ULTRASOUND
      4.2.4 COMPUTED TOMOGRAPHY (CT)
      4.2.5 FIXED & MOBILE MAGNETIC RESONANCE IMAGING (MRI) SYSTEM
      4.2.6 CATH LABS
      4.2.7 PET & SPECT SYSTEM
4.3 RADIATION ONCOLOGY SYSTEM
      4.3.1 LINEAR ACCELERATOR SYSTEM (LINAC)
      4.3.2 HDR SYSTEM
4.4 MINIMALLY INVASIVE DEVICES
      4.4.1 CATHETERS
      4.4.2 ENDOSCOPE
      4.4.3 GUIDE WIRES
      4.4.4 ATHERECTOMY DEVICES
      4.4.5 BALLOON PUMPS
      4.4.6 EMBOLIZATION DEVICES
      4.4.7 VASCULAR CLOSURE DEVICES
4.5 BIOTECHNOLOGY INSTRUMENTS
      4.5.1 MOLECULAR DIAGNOSTIC DEVICES
            4.5.1.1 Chromatography systems
            4.5.1.2 Electrophoresis systems
            4.5.1.3 Spectroscopic devices
            4.5.1.4 Immunoassay analyzers
            4.5.1.5 Sequencers & synthesizers
            4.5.1.6 PCR thermal cycler
      4.5.2 LAB INSTRUMENTS
            4.5.2.1 Centrifuge
            4.5.2.2 Homogenizer
            4.5.2.3 Incubators
            4.5.2.4 Flow cytometer
4.6 OTHERS

5 REGULATORY ANALYSIS
5.1 INTRODUCTION
5.2 NORTH AMERICA
      5.2.1 U.S.
            5.2.1.1 Legal aspects
            5.2.1.2 Governing/decision making committees
      5.2.2 CANADA
            5.2.2.1 Legal aspects
            5.2.2.2 Governing/decision making committees
5.3 EUROPE
      5.3.1 U.K.
            5.3.1.1 Legal aspects
            5.3.1.2 Governing/decision making committees
      5.3.2 GERMANY
            5.3.2.1 Legal aspects
            5.3.2.2 Governing/decision making committees
      5.3.3 FRANCE
            5.3.3.1 Legal aspects
            5.3.3.2 Governing/decision making committees
      5.3.4 SPAIN
      5.3.5 ITALY
            5.3.5.1 Legal aspects
            5.3.5.2 Governing/decision making committees
5.4 ASIA-PACIFIC
      5.4.1 INDIA
            5.4.1.1 Legal aspects
            5.4.1.2 Governing/decision making committees
      5.4.2 CHINA
            5.4.2.1 Legal aspects
            5.4.2.2 Governing/Decision making committees
      5.4.3 JAPAN
            5.4.3.1 Legal aspects
            5.4.3.2 Governing/decision making committees
      5.4.4 AUSTRALIA
            5.4.4.1 Legal aspects
            5.4.4.2 Governing/decision making committees
      5.4.5 NEW ZEALAND
            5.4.5.1 Legal aspects
      5.4.5.2 Governing/decision making committees
5.5 ROW

6 REFURBISHED MEDICAL EQUIPMENTS MARKET GEOGRAPHIC ANALYSIS
6.1 INTRODUCTION
6.2 NORTH AMERICA
6.3 EUROPE
6.4 ASIA
6.5 LATIN AMERICA
6.6 REST OF THE WORLD (ROW)

7 REFURBISHED MEDICAL EQUIPMENTS MARKET COMPETITIVE LANDSCAPE
7.1 INTRODUCTION
7.2 MERGERS & ACQUISITIONS
7.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
7.4 PRODUCTS LAUNCH
7.5 EXPANSIONS
7.6 OTHER DEVELOPMENTS

8 COMPANY PROFILES
8.1 AGITO MEDICAL A/S
      8.1.1 OVERVIEW
      8.1.2 FINANCIALS
      8.1.3 PRODUCTS & SERVICES
      8.1.4 STRATEGY
8.2 BIODIRECT, INC.
      8.2.1 OVERVIEW
      8.2.2 FINANCIALS
      8.2.3 PRODUCTS & SERVICES
      8.2.4 STRATEGY
8.3 DMS HEALTH TECHNOLOGIES
      8.3.1 OVERVIEW
      8.3.2 FINANCIALS
      8.3.3 PRODUCTS & SERVICES
      8.3.4 STRATEGY
      8.3.5 DEVELOPMENTS
8.4 EVERX PTY, LTD.
      8.4.1 OVERVIEW
      8.4.2 FINANCIALS
      8.4.3 PRODUCTS & SERVICES
8.5 FIRST SOURCE, INC.
      8.5.1 OVERVIEW
      8.5.2 FINANCIALS
      8.5.3 PRODUCTS & SERVICES
      8.5.4 STRATEGY
      8.5.5 DEVELOPMENTS
8.6 GE HEALTHCARE
      8.6.1 OVERVIEW
      8.6.2 FINANCIALS
      8.6.3 PRODUCTS & SERVICES
      8.6.4 STRATEGY
      8.6.5 DEVELOPMENTS
8.7 JOHNSON & JOHNSON
      8.7.1 OVERVIEW
      8.7.2 FINANCIALS
      8.7.3 PRODUCTS & SERVICES
      8.7.4 STRATEGY
      8.7.5 DEVELOPMENTS
8.8 OXFORD INSTRUMENTS, PLC
      8.8.1 OVERVIEW
      8.8.2 FINANCIALS
      8.8.3 PRODUCTS & SERVICES
      8.8.4 STRATEGY
      8.8.5 DEVELOPMENTS
8.9 RADIOLOGY ONCOLOGY SYSTEMS, INC.
      8.9.1 OVERVIEW
      8.9.2 FINANCIALS
      8.9.3 PRODUCTS & SERVICES
      8.9.4 STRATEGY
      8.9.5 DEVELOPMENTS
8.10 RELIANT MEDICAL SERVICES, INC.
      8.10.1 OVERVIEW
      8.10.2 FINANCIALS
      8.10.3 PRODUCTS & SERVICES
8.11 ROYAL PHILIPS HEALTHCARE
      8.11.1 OVERVIEW
      8.11.2 FINANCIALS
      8.11.3 PRODUCTS & SERVICES
      8.11.4 STRATEGY
      8.11.5 DEVELOPMENTS
8.12 SIEMENS HEALTHCARE
      8.12.1 OVERVIEW
      8.12.2 FINANCIALS
      8.12.3 PRODUCTS & SERVICES
      8.12.4 STRATEGY
      8.12.5 DEVELOPMENTS
8.13 STRYKER CORPORATION
      8.13.1 OVERVIEW
      8.13.2 FINANCIALS
      8.13.3 PRODUCTS & SERVICES
      8.13.4 STRATEGY
      8.13.5 DEVELOPMENTS
8.14 SOMA TECHNOLOGY, INC.
      8.14.1 OVERVIEW
      8.14.2 FINANCIALS
      8.14.3 PRODUCTS & SERVICES
      8.14.4 STRATEGY
      8.14.5 DEVELOPMENTS
8.15 TOSHIBA MEDICAL SYSTEMS CORPORATION
      8.15.1 OVERVIEW
      8.15.2 FINANCIALS
      8.15.3 PRODUCTS & SERVICES
      8.15.4 STRATEGY
      8.15.5 DEVELOPMENTS
8.16 ULTRA SOLUTIONS
      8.16.1 OVERVIEW
      8.16.2 FINANCIALS
      8.16.3 PRODUCTS & SERVICES
      8.16.4 STRATEGY
      8.16.5 DEVELOPMENTS:
8.17 UNISYN MEDICAL TECHNOLOGIES, INC.
      8.17.1 OVERVIEW
      8.17.2 FINANCIALS
      8.17.3 PRODUCTS & SERVICES
      8.17.4 STRATEGY
      8.17.5 DEVELOPMENTS
8.18 ZIEHM IMAGING GMBH
      8.18.1 OVERVIEW
      8.18.2 FINANCIALS
      8.18.3 PRODUCTS & SERVICES
      8.18.4 STRATEGY
      8.18.5 DEVELOPMENTS

LIST OF TABLES

TABLE 1 GLOBAL REFURBISHED MEDICAL DEVICES MARKET REVENUE,BY SEGMENTS, 2010 – 2017 ($MILLION)
TABLE 2 GLOBAL REFURBISHED MEDICAL DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 3 GLOBAL REFURBISHED IMAGING DIAGNOSTIC MONITORING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 4 GLOBAL REFURBISHED IMAGING DIAGNOSTIC MONITORING SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 5 GLOBAL REFURBISHED IMAGING DIAGNOSTIC MONITORING MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 6 REFURBISHED IMAGING DIAGNOSTIC MONITORING DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 7 REFURBISHED X-RAY DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 8 REFURBISHED X-RAY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 9 REFURBISHED C-ARM DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 10 REFURBISHED C-ARM DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 11 REFURBISHED ULTRASOUND DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 12 REFURBISHED ULTRASOUND DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 13 REFURBISHED CT DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 14 REFURBISHED CT DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 15 REFURBISHED FIXED & MOBILE MRI DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 16 FIXED & MOBILE MRI SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 17 REFURBISHED CATH LAB DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 18 REFURBISHED CATH LAB DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 19 REFURBISHED PET & SPECT DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 20 REFURBISHED PET & SPECT DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 21 RADIATION ONCOLOGY SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 22 RADIATION ONCOLOGY SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 23 REFURBISHED LINEAR ACCELERATOR SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 24 REFURBISHED LINEAR ACCELERATOR SYSTEMS MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 25 GLOBAL REFURBISHED HDR DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 26 REFURBISHED MINIMALLY INVASIVE DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 27 REFURBISHED MINIMALLY INVASIVE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 28 REFURBISHED MINIMALLY INVASIVE DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 29 REFURBISHED MINIMALLY INVASIVE DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 30 REFURBISHED CATHETER DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 31 REFURBISHED CATHETER DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 32 REFURBISHED ENDOSCOPIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 33 REFURBISHED ENDOSCOPIC DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 34 REFURBISHED GUIDEWIRE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 35 REFURBISHED GUIDEWIRE DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 36 REFURBISHED ATHERECTOMY DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 37 REFURBISHED ATHERECTOMY DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 38 GLOBAL REFURBISHED BALLOON PUMP DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 39 REFURBISHED BALLOON PUMP DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 40 REFURBISHED EMBOLIZATION DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 41 REFURBISHED EMBOLIZATION DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 42 REFURBISHED VASCULAR CLOSURE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 43 REFURBISHED VASCULAR CLOSURE DEVICES MARKET VOLUME, BY GEOGRAPHY, 2010 – 2017 (NO. OF UNITS)
TABLE 44 REFURBISHED BIOTECHNOLOGY INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 45 REFURBISHED BIOTECHNOLOGY INSTRUMENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 46 GLOBAL REFURBISHED MOLECULAR DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 47 REFURBISHED MOLECULAR DIAGNOSTIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 48 REFURBISHED CHROMATOGRAPHY SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 49 REFURBISHED ELECTROPHORESIS SYSTEMS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 50 REFURBISHED SPECTROSCOPIC DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 51 REFURBISHED IMMUNOASSAY ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 52 REFURBISHED SEQUENCERS & SYNTHESIZERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 53 REFURBISHED PCR THERMAL CYCLER DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 54 GLOBAL REFURBISHED LAB INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 55 REFURBISHED LAB INSTRUMENTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 56 REFURBISHED CENTRIFUGE DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 57 REFURBISHED HOMOGENIZER DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 58 REFURBISHED INCUBATOR DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 59 REFURBISHED FLOW CYTOMETER DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 60 COUNTRIES WITH PUBLIC PROCUREMENT POLICIES BARRING OR DISCOURAGING PURCHASE OF PRE-OWNED EQUIPMENT
TABLE 61 MARKETS THAT PERMIT THE IMPORTATION OF PRE-OWNED MEDICAL DEVICES
TABLE 62 COUNTRIES THAT RESTRICT THE IMPORTATION OF PRE-OWNED MEDICAL EQUIPMENT
TABLE 63 COUNTRIES THAT PROHIBIT THE IMPORTATION OF PRE-OWNED MEDICAL EQUIPMENT
TABLE 64 NORTH AMERICA: REFURBISHED DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 65 NORTH AMERICA: REFURBISHED IMAGING DIAGNOSTIC MONITORING SYSTEMS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 66 NORTH AMERICA: REFURBISHED MINIMALLY INVASIVE DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 67 NORTH AMERICA: REFURBISHED BIOTECHNOLOGY INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 68 NORTH AMERICA: REFURBISHED MOLECULAR DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 69 NORTH AMERICA: REFURBISHED LAB INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 70 NORTH AMERICA: REFURBISHED IMAGING DIAGNOSTIC MONITORING SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 71 NORTH AMERICA: REFURBISHED MINIMALLY INVASIVE DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 72 EUROPE: REFURBISHED DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 73 EUROPE: REFURBISHED IMAGING DIAGNOSTIC MONITORING MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 74 EUROPE: REFURBISHED MINIMALLY INVASIVE DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 75 EUROPE: REFURBISHED BIOTECHNOLOGY INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 76 EUROPE: REFURBISHED MOLECULAR DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 77 EUROPE: REFURBISHED LAB INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 78 EUROPE: REFURBISHED IMAGING DIAGNOSTIC MONITORING MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 79 EUROPE: REFURBISHED MINIMALLY INVASIVE DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 80 ASIA: REFURBISHED DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 81 ASIA: REFURBISHED IMAGING DIAGNOSTIC MONITORING MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 82 ASIA: REFURBISHED MINIMALLY INVASIVE DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 83 ASIA: REFURBISHED BIOTECHNOLOGY INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 84 ASIA: REFURBISHED MOLECULAR DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 85 ASIA: REFURBISHED LAB INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 86 ASIA: REFURBISHED IMAGING DIAGNOSTIC MONITORING SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 87 ASIA: REFURBISHED MINIMALLY INVASIVE DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 88 LATIN AMERICA: REFURBISHED DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 89 LATIN AMERICA: REFURBISHED IMAGING DIAGNOSTIC MONITORING MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 90 LATIN AMERICA: REFURBISHED MINIMALLY INVASIVE DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 91 LATIN AMERICA: REFURBISHED BIOTECHNOLOGY INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 92 LATIN AMERICA: REFURBISHED MOLECULAR DIAGNOSTIC DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 93 LATIN AMERICA: REFURBISHED LAB INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 94 LATIN AMERICA: REFURBISHED IMAGING DIAGNOSTIC MONITORING DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 95 LATIN AMERICA: REFURBISHED MINIMALLY INVASIVE DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 96 ROW: REFURBISHED MEDICAL DEVICES MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 97 ROW: REFURBISHED IMAGING DIAGNOSTIC MONITORING SYSTEMS MARKET REVENUE, BY TECHNOLOGIES, 2010 – 2017 ($MILLION)
TABLE 98 ROW: REFURBISHED MINIMALLY INVASIVE DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 99 ROW: REFURBISHED BIOTECHNOLOGY INSTRUMENTS MARKET REVENUE, BY PRICE RANGES, 2010 – 2017 ($MILLION)
TABLE 100 ROW: REFURBISHED MOLECULAR DIAGNOSTIC DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 101 ROW: REFURBISHED LAB INSTRUMENTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 102 ROW: REFURBISHED IMAGING-DIAGNOSTIC-MONITORING SYSTEMS MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 103 ROW: REFURBISHED MINIMALLY INVASIVE DEVICES MARKET VOLUME, BY PRODUCTS, 2010 – 2017 (NO. OF UNITS)
TABLE 104 MERGERS & ACQUISITIONS, 2009 – 2012
TABLE 105 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, 2009 – 2012
TABLE 106 PRODUCTS LAUNCH, 2009 – 2012
TABLE 107 EXPANSIONS, 2009 – 2012
TABLE 108 OTHER DEVELOPMENTS, 2009 – 2012
TABLE 109 GENERAL ELECTRIC COMPANY: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 110 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 111 GENERAL ELECTRIC COMPANY: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 112 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 113 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 114 JOHNSON & JOHNSON: MEDICAL DEVICES AND DIAGNOSTICS REVENUE, BY DIVISIONS, 2009 - 2011($MILLION)
TABLE 115 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 116 OXFORD INSTRUMENTS, PLC: TOTAL REVENUE AND R&D EXPENDITURE, 2010 - 2012 ($MILLION)
TABLE 117 OXFORD INSTRUMENTS, PLC: TOTAL REVENUE, BY SEGMENTS, 2010 - 2012 ($MILLION)
TABLE 118 ROYAL PHILIPS ELECTRONICS: NET SALES AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 119 ROYAL PHILIPS ELECTRONICS: NET SALES, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 120 PHILIPS HEALTHCARE: NET SALES, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 121 ROYAL PHILIPS ELECTRONICS: NET SALES, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 122 SIEMENS HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES, 2009 – 2011 ($MILLION)
TABLE 123 SIEMENS HEALTHCARE: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 124 SIEMENS HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 125 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, 2008 - 2010 ($MILLION)
TABLE 126 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 127 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2008 – 2010 ($MILLION)

LIST OF FIGURES

FIGURE 1 GEOGRAPHIC ANALYSIS, 2011
FIGURE 2 STEPS IN REFURBISHING
FIGURE 3 REFURBISHED MEDICAL DEVICES MARKET SEGMENTATION
FIGURE 4 MARKET DYNAMICS
FIGURE 5 GLOBAL REFURBISHED MEDICAL DEVICES MARKET SHARE, BY MAJOR PLAYERS, 2011
FIGURE 6 MEDICAL DEVICE REPROCESSING CYCLE
FIGURE 7 GLOBAL REFURBISHED MEDICAL DEVICES MARKET REVENUE, 2012 & 2017 ($MILLION)
FIGURE 8 PLANNED & EFFECTIVE LIFETIME OF REFURBISHED MEDICAL DEVICE
FIGURE 9 REFURBISHED IMAGING-DIAGNOSTIC-MONITORING DEVICES MARKET SEGMENTATION
FIGURE 10 GLOBAL REFURBISHED IMAGING-MONITORING-DIAGNOSTIC DEVICES MARKET REVENUE, 2010-2012 & 2017 ($MILLION)
FIGURE 11 REFURBISHED RADIATION ONCOLOGY SYSTEMS MARKET SEGMENTATION
FIGURE 12 GLOBAL REFURBISHED RADIATION ONCOLOGY DEVICES MARKET REVENUE, 2010-2012 & 2017 ($MILLION)
FIGURE 13 REFURBISHED MINIMALLY INVASIVE DEVICES MARKET SEGMENTATION
FIGURE 14 GLOBAL REFURBISHED MINIMALLY INVASIVE DEVICES MARKET REVENUE, 2010 - 2012 & 2017 ($MILLION)
FIGURE 15 REFURBISHED BIOTECHNOLOGY INSTRUMENTS MARKET SEGMENTATION
FIGURE 16 REFURBISHED MOLECULAR DIAGNOSTIC DEVICES MARKET SEGMENTATION
FIGURE 17 GLOBAL REFURBISHED MOLECULAR DIAGNOSTIC DEVICES MARKET REVENUE, 2010 - 2012 & 2017 ($MILLION)
FIGURE 18 REFURBISHED LAB INSTRUMENTS MARKET SEGMENTATION
FIGURE 19 GLOBAL REFURBISHED LAB INSTRUMENTS MARKET REVENUE, 2010 - 2012 & 2017 ($MILLION)
FIGURE 20 PROCESS FOLLOWED BY ORGANIZATIONS FOR REFURBISHMENT
FIGURE 21 NORTH AMERICA: REFURBISHED MEDICAL DEVICES MARKET REVENUE, 2012 & 2017 ($MILLION)
FIGURE 22 EUROPE: REFURBISHED MEDICAL DEVICES MARKET REVENUE, 2012 & 2017 ($MILLION)
FIGURE 23 ASIA: REFURBISHED MEDICAL DEVICES MARKET REVENUE, 2012 & 2017 ($MILLION)
FIGURE 24 LATIN AMERICA: REFURBISHED MEDICAL DEVICES MARKET REVENUE, 2012 & 2017 ($MILLION)
FIGURE 25 ROW: REFURBISHED MEDICAL DEVICES MARKET REVENUE, 2012 & 2017 ($MILLION)
FIGURE 26 KEY GROWTH STRATEGIES, FEBRUARY 2009 – JUNE 2012

Refurbishing of medical device refers to restoring used equipment or systems into a condition of safety and effectiveness comparable to new including actions such as repair, rework, update and replacement of worn parts with original parts. Refurbished products do not alter any product specification like remanufactured products, thus requiring no special approval to market the refurbished products in different countries. Refurbished medical devices represent the aftermarket of used medical devices worldwide. As per standard definition, refurbished devices hold a niche market which is different from remanufactured and used devices market.

The refurbished medical equipments/device market is under dramatic transformation globally and would see significant changes in the coming years, primarily driven by technological innovation, globalization and increasing acceptance in different developing countries Refurbishment is applicable for almost all medical devices but it is usually practiced for either highly expensive medical devices which are unaffordable for small and medium medical practitioners or frequently used medical devices which are prone to get damaged due to over-procurement by big hospitals. Refurbished products offer an exciting affordable price range that ranges between 40% and 60% off the original price of the equipments. This low pricing factor and enhanced access to replacement parts and repair technology are driving this market majorly.

The global refurbished medical devices market consisting of imaging-monitoring-diagnostic devices, radiation oncology systems, minimally invasive surgical devices, biotechnology instruments and others is poised to grow at a CAGR of 7.8% to reach $8.5 billion by 2017. In 2012, 78% of the refurbished market is contributed by imaging-monitoring-diagnostic devices and biotechnology instruments. These markets are followed by refurbished minimally invasive devices. Radiotherapy devices market is relatively new and unsaturated market.

Among refurbished imaging-monitoring-diagnostic devices, Computed Tomography (CT), Ultrasound and fixed & mobile MRI (Magnetic Resonance Imaging) contribute 60% to the market and fixed & mobile MRI (Magnetic Resonance Imaging) is expected to grow robustly in the coming years. In refurbished biotechnology instruments, highly expensive chromatography, electrophoresis and spectroscopic devices are in high demand.

The trend in various geographical markets is shaping differently with its unique pace. North America and Latin America have accepted these refurbished medical devices generously. Developed countries such as Asia and Middle East are the most promising geographic realms for this niche market. This market does not fetch much interest in the Europe market due to conventional socialized medicine practices. A few important markets like China, Brazil, Australia and Japan have restricted the importation of refurbished medical devices.

Refurbished Medical Equipments Market share analysis

Refurbished Medical Devices Market